SUSTAINABILITY MEETING

Aiming to Enhance the Sustainability of Society and Astellas' Corporate Value

Kenji Yasukawa, Ph.D.

President and CEO

Astellas Pharma Inc.

February 28, 2022

CAUTIONARY STATEMENT REGARDING FORWARD-

2

LOOKING INFORMATION

In this material, statements made with respect to current plans, estimates, strategies and beliefs and other statements that are not historical facts are forward-looking statements about the future performance of Astellas Pharma. These statements are based on management's current assumptions and beliefs in light of the information currently available to it and involve known and unknown risks and uncertainties. A number of factors could cause actual results to differ materially from those discussed in the forward-looking statements. Such factors include, but are not limited to: (i) changes in general economic conditions and in laws and regulations, relating to pharmaceutical markets, (ii) currency exchange rate fluctuations, (iii) delays in new product launches, (iv) the inability of Astellas to market existing and new products effectively, (v) the inability of Astellas to continue to effectively research and develop products accepted by customers in highly competitive markets, and (vi) infringements of Astellas' intellectual property rights by third parties.

Information about pharmaceutical products (including products currently in development) which is included in this material is not intended to constitute an advertisement or medical advice.

VISION

3

-On the forefront of healthcare change to turn innovative science into VALUE for patients-

Astellas'

VISION

sustainable growth

Corporate

Strategic

Strategic Goals

Plan

2021

1

2

3

Enable patients to

Translate

Advance the Rx+

achieve better

innovative science

business

outcomes

into proven VALUE

4

Deepen our engagement in sustainability

Organizational Health Goals

Sustainability* of Society

Human capital

Social and

relationship

capital

Natural capital

  1. Promoting Innovation
  2. Talent & Leadership thrives
  3. Penetration of collaboration

Fostering a corporate culture that aims to achieve ambitious goals

Significantly improving Astellas' implementation capabilities

Intellectual

capital

*IIRC: Integrated Reporting Framework

AGENDA

4

I

Improving Access to Health

IV

II

Climate Change Measures

V

III

Corporate Governance

VI

People and Organizational Development

Materiality Matrix

Items That We Perceive to Be Expected by The Stock Market

IMPROVING ACCESS TO HEALTH

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Astellas Pharma Inc. published this content on 28 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 February 2022 03:11:03 UTC.